CONOR MAGUIRE: Open Payments
NPI 1093488801 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$699 in 27 payments from 11 companies in 2025. Trend: 2023 $1,228 · 2024 $952 · 2025 $699
Food & beverage: $699
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $274 |
| AstraZeneca Pharmaceuticals LP | 5 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $71 |
| SCPHARMACEUTICALS INC. | 2 | $52 |
| Daiichi Sankyo Inc. | 3 | $44 |
| CSL Behring | 1 | $35 |
| Kestra Medical Technology Services, Inc. | 1 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| BridgeBio Pharma, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $21 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, JARDIANCE, FARXIGA, FUROSCIX, INJECTAFER, Kcentra, Assure WCD, AMVUTTRA.
Industry payments across NY — which companies pay providers there.
